Wednesday, 19 February 2020

Vaccines News

  • WHO: Bird flu is back in China

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family Planning Commission to World Health Organization (WHO). The cases we...Read more

  • FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-culture-derived vaccine, for individuals 18 years of age and older. Develo...Read more

  • Takeda acquires LigoCyte Pharmaceuticals at $60 mn

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

  • FDA approves GSK's combo meingitis vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Men...Read more

  • Biodiem gets US patent allowance for antifungal therapy

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

  • Arterial Remodeling Technologies receives regulatory approval

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

      Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccin...Read more

  • 'China's H7N9 outbreak an epidemic'

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

    Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more

  • MR vaccine drive for all

    Vaccines |  News | 0 Comment | 13 Apr, 2017

    To quell the rumours around the measles-rubella vaccine, UNICEF has reached out to Islamic civil society organisations, religious leaders and academia to create trust and address myths arou...Read more

  • Globally Zika Virus vaccines market expected to reach $18,697 mn by 2022

    Vaccines |  News | 0 Comment | 04 Jan, 2017

    A new report published by Allied Market Research, titled, “Potential Market for Zika Virus Vaccines: Global Opportunity Analysis and Industry Forecast, 2017–2022”, project...Read more

  • CEPI board meeting with a focus on identifying disease priorities and future strategy

    Vaccines |  News | 0 Comment | 19 Dec, 2016

    The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more